INVO Fertility (IVF) EBT Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.34% |
| Jun 30, 2025 | -19.39% |
| Mar 31, 2025 | -64.51% |
| Dec 31, 2024 | -36.11% |
| Sep 30, 2024 | -18.69% |
| Jun 30, 2024 | -56.19% |
| Mar 31, 2024 | -28.31% |
| Dec 31, 2023 | -20.65% |
| Sep 30, 2023 | -33.42% |
| Jun 30, 2023 | -3.71% |
| Mar 31, 2023 | -77.51% |
| Dec 31, 2022 | -68.85% |
| Sep 30, 2022 | -76.50% |
| Jun 30, 2022 | -82.86% |
| Mar 31, 2022 | -65.92% |
| Dec 31, 2021 | 18.82% |
| Sep 30, 2021 | -63.74% |
| Jun 30, 2021 | -4.54% |
| Mar 31, 2021 | -68.37% |
| Dec 31, 2020 | -73.23% |
| Sep 30, 2020 | -70.44% |
| Jun 30, 2020 | 21.53% |
| Mar 31, 2020 | -58.44% |
| Dec 31, 2019 | 9.69% |
| Sep 30, 2019 | -42.01% |
| Jun 30, 2019 | -5.28% |
| Mar 31, 2019 | -31.34% |
| Dec 31, 2018 | -40.85% |
| Sep 30, 2018 | -6.62% |
| Jun 30, 2018 | -77.83% |
| Mar 31, 2018 | 13.72% |
| Dec 31, 2017 | -36.15% |
| Sep 30, 2017 | 9.14% |
| Jun 30, 2017 | 0.34% |
| Mar 31, 2017 | 2.49% |
| Dec 31, 2016 | -7.50% |
| Sep 30, 2016 | -16.27% |
| Jun 30, 2016 | -36.52% |